MARC Record from marc_columbia

LEADER: 09260cam a2200493 a 4500
001 7831923
005 20221201040049.0
008 100112t20102010paua b 001 0 eng
010 $a 2010001262
015 $aGBB000933$2bnb
016 7 $a101522644$2DNLM
016 7 $a015453548$2Uk
019 $a437297704
020 $a9781582558202 (alk. paper)
020 $a1582558205 (alk. paper)
035 $a(OCoLC)ocn495597525
035 $a(OCoLC)495597525$z(OCoLC)437297704
035 $a(NNC)7831923
035 $a7831923
040 $aDNLM/DLC$cDLC$dYDX$dBTCTA$dNLM$dUKM$dYDXCP$dOrLoB-B
042 $apcc
050 00 $aRC112$b.T73 2010
060 10 $aWO 660$bT691 2010
082 00 $a617.9/5$222
245 00 $aTransplant infections /$ceditors, Raleigh A. Bowden, Per Ljungman, David R. Snydman.
250 $a3rd ed.
260 $aPhiladelphia :$bWolters Kluwer Health/Lippincott Williams & Wilkins,$c[2010], ©2010.
300 $axii, 788 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gSection I.$tIntroduction to Transplant Infections -- $g1.$tIntroduction to Hematopoietic Cell Transplantation /$rH. Joachim Deeg -- $g2.$tIntroduction to Solid Organ Transplantation /$rBarry D. Kahan -- $g3.$tImmunosuppressive Agents /$rRichard Freeman -- $g4.$tCommon Drug Interactions Encountered in Treating Transplant-Related Infections /$rLisa M. McDevitt -- $gSection II.$tRisks and Epidemiology of Infections after Transplantation -- $g5.$tRisks and Epidemiology of Infections after Allogeneic Hematopoietic Stem Cell Transplantation /$rJuan Gea-Banacloche -- $g6.$tRisks and Epidemiology of Infections after Solid Organ Transplantation /$rEmily A. Blumberg -- $g7.$tDonor-Derived Infections: Incidence, Prevention and Management /$rMichael G. Ison -- $g8.$tTransplant Infections in Developing Countries /$rClarisse M. MacHado -- $g9.$tRisks and Epidemiology of Infections after Heart Transplantation /$rDavid R. Snydman -- $g10.$tRisks and Epidemiology of Infections after Lung or Heart---Lung Transplantation /$rAlbert Pahissa -- $g11.$tInfections in Kidney Transplant Recipients /$rAtul Humar -- $g12.$tRisks and Epidemiology of Infections after Pancreas or Kidney-Pancreas Transplantation /$rAbhinav Humar -- $g13.$tRisks and Epidemiology of Infections after Liver Transplantation /$rDavid C. Mulligan -- $g14.$tRisks and Epidemiology of Infections after Intestinal Transplantation /$rMichael Green -- $gSection III.$tSpecific Sites of Infection -- $g15.$tPneumonia after Hematopoietic Stem Cell or Solid Organ Transplantation /$rIsabel Cunningham -- $g16.$tSkin Infections after Hematopoietic Stem Cell or Solid Organ Transplantation /$rW. P. Daniel Su -- $g17.$tCentral Nervous System Infections after Hematopoietic Stem Cell or Solid Organ Transplantation /$rDan Engelhard -- $g18.$tGastrointestinal Infections after Solid Organ or Hematopoietic Cell Transplantation /$rGideon Steinbach -- $gSection IV.$tBacterial Infections -- $g19.$tGram-Positive and Gram-Negative Infections after Hematopoietic Stem Cell or Solid Organ Transplantation /$rDan Engelhard -- $g20.$tTypical and Atypical Mycobacterium Infections after Hematopoietic Stem Cell or Solid Organ Transplantation /$rDaniel J. Weisdorf -- $g21.$tOther Bacterial Infections after Hematopoietic Stem Cell or Solid Organ Transplantation /$rTue Ngo -- $gSection V.$tViral Infections -- $g22.$tCytomegalovirus Infection after Stem Cell Transplantation /$rPer Ljungman -- $g23.$tCytomegalovirus Infection after Solid Organ Transplantation /$rAjit P. Limaye -- $g24.$tEpstein-Barr Virus Infection and Lymphoproliferative Disorders after Transplantation /$rSandra M. Cockfield -- $g25.$tHerpes Simplex and Varicella-Zoster Virus Infection after Hematopoietic Stem Cell or Solid Organ Transplantation /$rJohn W. Gnann, Jr. -- $g26.$tInfections with Human Herpesvirus-6, -7, and -8 after Hematopoietic Stem Cell or Solid Organ Transplantation /$rNina Singh -- $g27.$tCommunity-Acquired Respiratory Viruses after Hematopoietic Stem Cell or Solid Organ Transplantation /$rEstella Whimbey -- $g28.$tAdenovirus Infection in Allogeneic Stem Cell Transplantation /$rSusanne Matthes-Martin -- $g29.$tAdenovirus Infection in Solid Organ Transplantation /$rMarian G. Michaels -- $g30.$tPolyoma and Papilloma Virus Infections after Hematopoietic Cell or Solid Organ Transplantation /$rHans H. Hirsch -- $g31.$tHepatic Infections after Solid Organ Transplantation /$rEd Gane -- $g32.$tHepatitis B and C in Hematopoietic Stem Cell Transplant /$rMaria Beatrice Pinazzi -- $gSection VI.$tFungal Infections -- $g33.$tYeast Infections after Hematopoietic Stem Cell Transplantation /$rThomas J. Walsh -- $g34.$tYeast Infections after Solid Organ Transplantation /$rPeter G. Pappas -- $g35.$tMold Infections after Hematopoietic Stem Cell Transplantation /$rKieren A. Marr -- $g36.$tAspergillus and Other Mold Infections after Solid Organ Transplant /$rEmilio Bouza -- $g37.$tInfections Caused by Uncommon Fungi in Patients Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation /$rThomas J. Walsh -- $g38.$tEndemic Mycoses after Hematopoietic Stem Cell or Solid Organ Transplantation /$rCarol A. Kauffman -- $gSection VII.$tOther Infections -- $g39.$tToxoplasmosis Following Hematopoietic Stem Cell Transplantation /$rRodrigo Martino -- $g40.$tToxoplasmosis after Solid Organ Transplantation /$rMitchell R. Lunn -- $g41.$tParasites after Hematopoietic Stem Cell or Solid Organ Transplantation /$rMarcelo Radisic -- $gSection VIII.$tInfection Control -- $g42.$tInfection Control Issues after Hematopoietic Stem Cell Transplantation /$rDavid L. Longworth -- $g43.$tInfection Control Issues after Solid Organ Transplantation /$rShimon Kusne -- $gSection IX.$tImmune Reconstitution Strategies for Prevention and Treatment of Infections -- $g44.$tVaccination of Transplant Recipients /$rPer Ljungman -- $g45.$tGrowth Factors and Other Immunomodulators after Transplantation /$rJohn R. Wingard -- $g46.$tAdoptive Immunotherapy with Herpesvirus-specific T Cells after Transplantation /$rStanley R. Riddell -- $gSection X.$tHot Topics -- $g47.$tEmerging and Rare Viral Infections in Transplantation /$rStaci A. Fischer -- $g48.$tTravel Medicine, Vaccines and Transplant Tourism /$rCamille Nelson Kotton.
520 1 $a"All rights reserved. This book is protected by copyright. No part of this book may be reproduced in any form by any means, including photocopying, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book prepared by individuals as part of their official duties as U.S. government employees are not covered by the above-mentioned copyright." "Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in this book and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of the publication. Application of the information in a particular situation remains the professional responsibility of the practitioner." "The authors, editors, and publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or infrequently employed drug." "Some drugs and medical devices presented in the publication have Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the health care provider to ascertain the FDA status of each drug or device planned for use in their clinical practice."--BOOK JACKET.
650 0 $aCommunicable diseases.$0http://id.loc.gov/authorities/subjects/sh85029015
650 0 $aTransplantation of organs, tissues, etc.$xComplications.$0http://id.loc.gov/authorities/subjects/sh92000042
650 0 $aNosocomial infections.$0http://id.loc.gov/authorities/subjects/sh85092770
650 12 $aTransplants$xadverse effects.
650 22 $aBacterial Infections$xetiology.$0https://id.nlm.nih.gov/mesh/D001424Q000209
650 22 $aMycoses$xetiology.$0https://id.nlm.nih.gov/mesh/D009181Q000209
650 22 $aVirus Diseases$xetiology.$0https://id.nlm.nih.gov/mesh/D014777Q000209
700 1 $aBowden, Raleigh A.$0http://id.loc.gov/authorities/names/nb99027324
700 1 $aLjungman, Per.$0http://id.loc.gov/authorities/names/nb99027326
700 1 $aSnydman, David R.$0http://id.loc.gov/authorities/names/n00121305
852 00 $boff,hsl$hRC112$i.T73 2010 Q